KRMD Earnings Date: Nov 10, 2026 (Estimated) — KORU Medical Systems, Inc.
NASDAQ · Healthcare · Medical Instruments & Supplies
Updated
When is KRMD's next earnings date?
KORU Medical Systems, Inc. (KRMD) is expected to report Q3 2026 earnings on Tuesday, November 10, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.02 on revenue of $11.3M.
How did KRMD do in its last earnings report?
In its most recent report on Aug 5, 2026 (Q2 2026), KORU Medical Systems, Inc. posted EPS of $0.02 versus the -$0.02 estimate, a beat of 300.0%. Revenue was $12.0M against a $11.6M estimate. The stock's 1-day post-earnings move was -13.8%.
How much does KRMD stock move after earnings?
KRMD beat EPS estimates in 7 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 12.1% (up or down) in the day after earnings.
About KORU Medical Systems, Inc.
KORU Medical Systems, Inc. is dedicated to the development, manufacturing, and commercialization of mobile medical devices, primarily serving the ambulatory infusion market across both the United States and international territories. The company's primary offerings revolve around mechanical infusion solutions, notably their FREEDOM infusion systems. These comprehensive systems encompass components such as the FREEDOM60 and FreedomEdge syringe drivers, alongside specialized HIgH-Flo subcutaneous safety needle sets and precision flow rate tubing. Beyond their product range, KORU Medical also supplies educational content and training materials to healthcare professionals, patients, and patient advocates. The distribution of their products is managed through a combination of direct sales efforts, partnerships with medical device distributors, and online channels. Established in 1980, the firm's corporate headquarters are situated in Chester, New York.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-05 | Q2 2026 | -0.02 | 0.02 | +300.00% | $12.0M | ✅ Beat | -13.80% | -20.10% | -22.03% |
| 2026-05-06 | Q1 2026 | -0.01 | 0.00 | +100.00% | $11.8M | ✅ Beat | +10.72% | -3.99% | -2.00% |
| 2026-03-12 | Q4 2025 | -0.02 | 0.01 | +150.00% | $10.9M | ✅ Beat | -0.70% | -0.23% | +0.70% |
| 2025-11-12 | Q3 2025 | -0.03 | 0.00 | +100.00% | $10.4M | ✅ Beat | +15.08% | +15.08% | +52.91% |
| 2025-08-06 | Q2 2025 | -0.02 | 0.01 | +150.00% | $10.2M | ✅ Beat | +18.71% | +31.90% | +24.54% |
| 2025-03-12 | Q4 2024 | -0.02 | -0.02 | +0.00% | $8.8M | ➖ Inline | -17.68% | -10.98% | -30.49% |
| 2024-11-13 | Q3 2024 | -0.04 | -0.01 | +75.00% | $8.2M | ✅ Beat | -3.75% | +14.06% | +34.38% |
| 2024-08-07 | Q2 2024 | -0.04 | -0.01 | +75.00% | $8.4M | ✅ Beat | +16.43% | +8.45% | +15.49% |
Showing last 8 quarters.
Revenue by segment & region
By region
Q2 FY26 · $12.0M total
| Segment | Share | Revenue | YoY | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|
| UNITED STATES | 69.7% | $8.4M | +4.8% | $6.7M | $15.5M | $8.4M | $8.4M |
| Non-US | 30.3% | $3.6M | +67.2% | $3.7M | $5.0M | $3.3M | $3.6M |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.